Table 2.
Representative natural products coordinated with Fe2+/3+
| NO | Natural Products | Metal ions | Preparation | TME Response |
Size | Treatment | Bioimaging | Reference |
|---|---|---|---|---|---|---|---|---|
| 1 | Dopamine, DA | Fe3+ | Mixing | pH, GSH | 204 nm | CT/CDT/PTT | —— | [39] |
| 2 | Tannic acid, TA | Fe3+ | – | pH | 95.6 nm | CT/PTT | MRI | [33] |
| 3 | Tannic acid, TA | Fe3+ | Stirring and Ultrasound | pH, ATP | 121.17 nm | CT/PTT | PAI/MRI/PTI | [32] |
| 4 | Tannic acid, TA | Fe3+ | – | ATP | 257 nm | CDT/CT | PAI/FI | [35] |
| 5 | Tannic acid, TA | Fe3+ | – | NIR | > 200 nm | PTT | MRI/PTI | [31] |
| 6 | Ellagic acid, EA | Fe3+ | Magnetic stirring | TME | 25 nm | PTT | PAI/MRI | [38] |
| 7 | Porphyrin | Fe3+ | Stirring | pH, GSH | 145 ± 20 nm | CDT/PDT | FI/MRI | [41] |
| 8 | Hematoporphyrin monomethyl ether, HMME | Fe3+ | Magnetic stirring | pH, US | ~ 70 nm | CT | MRI | [42] |
| 9 | Gallic acid, GA | Fe3+ | – | pH | 110 nm | CT/PTT | MRI | [36] |
| 10 | Artemisinin, ART | Fe3+ | Magnetic stirring | pH, GSH | 80 ± 8.9 nm | CT/CDT | MRI | [44] |
| 11 | Tartaric acid, TA | Fe3+ | Magnetic stirring | pH | ~ 125 nm | CDT/PTT | PTI | [60] |
| 12 | Tannic acid, TA | Fe3+ | – | – | 260.13 ± 1.86 nm | PTT/ICD | PTI | [34] |
| 13 | Tannic acid, TA | Fe3+ | – | pH, ATP | < 500 nm | CT/PTT | – | [61] |
| 14 | Tannic acid, TA | Fe2+ | – | pH | – | CT | – | [45] |
| 15 | Doxorubicin, DOX | Fe3+ | – | pH | – | CT | – | [15] |
| 16 | Gallic acid, GA | Fe3+ | – | pH | 200 nm | CT/CDT | MRI/PTI | [37] |
| 17 | Baicalein | Fe2+ | Stirring | —— | 160 nm | CDT/PTT | – | [62] |
| 18 | Epigallocatechin-3-gallate, EGCG | Fe3+ | Magnetic stirring | pH | ~ 100 nm | CT/CDT | FI/MRI | [46] |
| 19 | Gallic acid, GA | Fe3+ | —— | pH | 200 nm | CT/CDT | – | [63] |
| 20 | Dopamine, DA | Fe3+ | Magnetic stirring | pH | 60 nm | PTT | PAI/PTI | [40] |
| 21 | Pemetrexed, PEM; pseudolaric acid B, PAB | Fe3+ | Coordination-driven co-assembly | pH | 100 nm | CT | MRI/FLI | [43] |
| 22 | Shikonin | Fe3+ | Magnetic stirring | GSH | 48.2 ± 5.4 nm | CT/CDT | MRI | [47] |
| 23 | Quercetin, QU; methotrexate, MTX | Fe3+ | Magnetic stirring | pH | 181 ± 2 nm | ICD/CT | FI | [56] |
| 24 | Gallic acid, GA | Fe2+ | – | pH | 210.1 nm | CT/CDT | FI | [64] |
| 25 | Hematoxylin, HMT | Fe3+ | In vivo self-assembly | – | – | PTT/ICD | PTI | [65] |
| 26 | SiRNA | Fe2+ | Quick ultrasonic | pH | 180 nm | CT/CDT | MRI | [59] |
| 27 | Polyaminopyrrole, Py-NH2 | Fe3+ | Magnetic stirring | TME | 54.3 nm | PTT | PAI/MRI | [66] |
| 28 | GAPDH SiRNA | Fe2+ | Magnetic stirring | – | – | CDT | FI | [67] |
| 29 | Tannic acid, TA | Fe3+ | Magnetic stirring | pH | 45.0 nm | CT/CDT/IT | MRI | [68] |
| 30 | Benzoic acid, TCPP | Fe3+ | Stirring | – | 245.2 ± 11.2, 58.1 ± 4.8 nm | PDT/CDT | —— | [69] |
| 31 | Green tea polyphenols, GTP | Fe3+ | Ultrasonic | pH | 274 nm | CT/PTT/IT | —— | [49] |
| 32 | Croconaine | Fe3+ | —— | GSH/pH | 91.3 ± 10.4 nm | PTT/CDT | PAI/PTI | [55] |
| 33 | Doxorubicin, DOX | Fe2+ | Magnetic stirring | pH/H2O2 | ∼110 nm | CT/CDT/ICD | FI | [70] |
| 34 | Cinnamaldehyde, CA; DOX | Fe3+ | Magnetic stirring | pH/H2O2 | ~ 100 nm | CT/CDT | – | [57] |
| 35 | Doxorubicin, DOX | Fe3+ | Magnetic stirring | pH | 77.3 ± 5.3 nm | CT | – | [71] |
| 36 | Hyaluronic acid, HA | Fe3+ | Magnetic stirring | pH | 225 nm | PTT | PAI | [72] |
| 37 | Artemisinin, ART; TiO2 | Fe3+ | Magnetic stirring | —— | 170 ± 20 nm | SDT/CDT | – | [73] |
| 38 | Amino acids | Fe3+ | —— | TME | 100–140 nm | – | [74] | |
| 39 | Gallic acid, GA; 5-fluorouracil | Fe3+ | Magnetic stirring | DFO | 139 nm | CT/PTT | PAI/PTI | [50] |
| 40 | Epigallocatechin gallate, EGCG | Fe3+ | Magnetic stirring | pH | 123.7 nm | PTT/CDT/CT | FI | [75] |
| 41 | Epigallocatechin gallate, EGCG | Fe3+ | Magnetic stirring | TME | 240 nm | PTT/PDT/ | FI/PTI | [52] |
| 42 | Tannic acid, TA | Fe3+ | Magnetic stirring; Ultrasonic | pH | 200 nm | CDT/ICD | FI | [76] |
| 43 | Polydopamine, PDA | Fe3+ | Magnetic stirring | hyperthermia/pH | 129.1 ± 6.6 nm | CDT/PTT | FI/PTI | [77] |
| 44 | DNAzyme | Fe3+ | Vortex | pH | 200 nm | CDT/CT | FI | [78] |
| 45 | Gossypol | Fe3+ | Solvothermal Decomposition | pH/laser | ~ 60 nm | CT/PTT | FI/MRI | [58] |
| 46 | Lenvatinib, Adriamycin | Fe3+ | – | pH | 121 ± 3.74 nm | CT/ICD | FI | [79] |
| 47 | Apigenin | Fe3+ | Magnetic stirring | pH/GSH | 264.7 ± 56.2 nm | FI/MRI | [80] |